Allopurinol and Pathogenesis of Cirrhosis

• Status: COMPLETED
• Trial end date: 2024-03-01

Summary

Hepatic decompensation is a common healthcare issue

. This study was conducted to investigate how allopurinol can interfere with the pathological mechanisms of HD.

• Phase: PHASE1

Details

• Lead Sponsor: Tanta University
• Treatments: Allopurinol